1. Home
  2. EDAP vs DMA Comparison

EDAP vs DMA Comparison

Compare EDAP & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • DMA
  • Stock Information
  • Founded
  • EDAP 1979
  • DMA 2011
  • Country
  • EDAP France
  • DMA United States
  • Employees
  • EDAP N/A
  • DMA N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DMA Trusts Except Educational Religious and Charitable
  • Sector
  • EDAP Health Care
  • DMA Finance
  • Exchange
  • EDAP Nasdaq
  • DMA Nasdaq
  • Market Cap
  • EDAP 75.5M
  • DMA 78.3M
  • IPO Year
  • EDAP 1997
  • DMA N/A
  • Fundamental
  • Price
  • EDAP $2.00
  • DMA $8.81
  • Analyst Decision
  • EDAP Buy
  • DMA
  • Analyst Count
  • EDAP 3
  • DMA 0
  • Target Price
  • EDAP $8.50
  • DMA N/A
  • AVG Volume (30 Days)
  • EDAP 81.7K
  • DMA 34.6K
  • Earning Date
  • EDAP 11-06-2025
  • DMA 01-01-0001
  • Dividend Yield
  • EDAP N/A
  • DMA 2.04%
  • EPS Growth
  • EDAP N/A
  • DMA N/A
  • EPS
  • EDAP N/A
  • DMA N/A
  • Revenue
  • EDAP $74,853,925.00
  • DMA N/A
  • Revenue This Year
  • EDAP N/A
  • DMA N/A
  • Revenue Next Year
  • EDAP N/A
  • DMA N/A
  • P/E Ratio
  • EDAP N/A
  • DMA N/A
  • Revenue Growth
  • EDAP 0.61
  • DMA N/A
  • 52 Week Low
  • EDAP $1.21
  • DMA $4.78
  • 52 Week High
  • EDAP $3.05
  • DMA $8.00
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 45.90
  • DMA 64.35
  • Support Level
  • EDAP $1.82
  • DMA $8.56
  • Resistance Level
  • EDAP $2.24
  • DMA $8.87
  • Average True Range (ATR)
  • EDAP 0.21
  • DMA 0.07
  • MACD
  • EDAP -0.02
  • DMA 0.02
  • Stochastic Oscillator
  • EDAP 46.38
  • DMA 86.55

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.

Share on Social Networks: